Ovarian cancer typically presents at advanced stages, with prognosis heavily influenced by the presence of residual disease following cytoreductive surgery. The role of resecting enlarged extra-abdominal lymph nodes during cytoreductive procedures remains contentious. These enlarged lymph nodes are commonly identified through high-resolution imaging techniques such as ultrasound (US), computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography–computed tomography (PET-CT). A comprehensive understanding of the relevant anatomy, imaging modalities, and surgical techniques for addressing lymphadenopathy in regions such as the supraclavicular fossa, axillae, mediastinum, and pericardiophrenic fat is crucial in determining the feasibility of surgical intervention. An appropriate evaluation of these factors is essential to optimize debulking, which is recognized as the most significant prognostic determinant in patients with ovarian cancer. This review underscores the importance of multidisciplinary approaches in managing advanced ovarian cancer with extra-abdominal lymph node involvement to enhance patient outcomes.
卵巢癌通常于晚期阶段确诊，其预后在很大程度上受细胞减灭术后残留病灶的影响。在细胞减灭手术中切除增大的腹腔外淋巴结的作用仍存在争议。这些增大的淋巴结通常通过高分辨率影像学技术如超声（US）、计算机断层扫描（CT）、磁共振成像（MRI）以及正电子发射断层扫描-计算机断层扫描（PET-CT）进行识别。全面了解锁骨上窝、腋窝、纵隔及心包膈脂肪等区域淋巴结病变的相关解剖结构、影像学检查方法及手术技术，对于确定手术干预的可行性至关重要。对这些因素进行恰当评估对于优化肿瘤减灭术至关重要，而肿瘤减灭术被认为是卵巢癌患者最重要的预后决定因素。本综述强调了多学科方法在处理伴有腹腔外淋巴结转移的晚期卵巢癌中的重要性，以改善患者预后。
肿瘤(癌症)患者之家